U.S. Pharmacist
VerifiedJournal
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry, and academia. The publication is also useful to pharmacy technicians, students, other health professionals, and individuals interested in health management. Pharmacists licensed in the United States can earn Continuing Education credits through U.S. Pharmacist. Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Source
Actions
Media Outlet details
| Scope | National, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Monthly |
| Accepts contributed content | Yes |
Recent Articles
Search Articles2024–2025 COVID-19 Vaccine Linked to Lower CV Event Risk in Veterans
News and Trends • Published July 3, 2026 Receipt of the 2024–2025 COVID-19 vaccine was associated with a reduced risk of major adverse cardiovascular events among U.S. veterans, according to a study published in JAMA Internal Medicine. The greatest benefit was observed among adults older than 75 years and those with comorbidities.
Survey Finds Patients View CGM as Useful, Empowering Tool
Diabetes Technology • Published July 3, 2026 Results of an online survey published in JMIR Formative Research suggest that adults with type 2 diabetes (T2DM) generally view continuous glucose monitoring (CGM) as a valuable tool for understanding glucose patterns and supporting diabetes self-management. However, cost, limited access, usability concerns, and emotional and data-related burdens remain barriers to broader use.
COVID-19 mRNA Vaccination Still Recommended During Cancer Immunotherapy
News and Trends • Published July 3, 2026 COVID-19 mRNA vaccination was associated with a modest but clinically meaningful increase in immune-related adverse events among patients with cancer receiving immune checkpoint inhibitors, according to a study published in the Journal for ImmunoTherapy of Cancer. However, researchers said the survival benefits outweighed these risks, supporting continued vaccination for eligible patients with heightened monitoring.
CGM May Complement Standard Tests for Prediabetes Detection
News and Trends • Published July 3, 2026 Continuous glucose monitoring (CGM) metrics may help identify early abnormalities in glucose regulation and provide information complementary to conventional laboratory tests used to classify prediabetes, according to a study published in Diabetes Research and Clinical Practice.
HbA1c and CGM Together May Improve Glucose Assessment in Older Adults
Diabetes Technology • Published July 3, 2026 Long-term changes in hemoglobin A1C (HbA1c) and continuous glucose monitoring (CGM) metrics may not always align in older adults with type 2 diabetes (T2DM), suggesting that using both measures could provide a more complete assessment of glycemic control, according to a study published in Clinical Chemistry. The study evaluated changes in HbA1c and CGM metrics over approximately 1 year among older adults with T2DM.
Same-Day COVID-19 and Flu Vaccination Not Linked to Higher Adverse Event Risk
News and Trends • Published July 3, 2026 Receiving COVID-19 and influenza vaccines on the same day was not associated with an increased risk of adverse events, according to a large nationwide study published in Annals of Internal Medicine. The findings support the safety of coadministration across several updated COVID-19 vaccine formulation periods.
Study Highlights Factors Linked to Rheumatoid Arthritis Self-Management
Specialty Pharmacy • Published July 3, 2026 Treatment adherence, positive psychological factors, and social support may contribute to better self-management among patients with rheumatoid arthritis, according to a scoping review published in the Journal of Clinical Rheumatology. The review found that physical impairment and negative psychological factors, including depression and anxiety, were associated with poorer outcomes related to self-efficacy.
Postoperative Opioid Prescribing Inconsistent Among Children
News and Trends • Published July 3, 2026 Chicago—Whether children are prescribed opioids for postsurgical pain varies widely according to what type of procedure they have had and where they have it, according to a new national analysis. A new national analysis published in the Journal of the American College of Surgeons (JACS) found that overall, nearly one-third of children are prescribed opioids after surgery.
AI in Healthcare News Digest
US Pharm. 2026;51(6):44-47. AI Identifies Early Risk Patterns for Skin Cancer Researchers analyzed registry data covering the entire adult population of Sweden to explore new ways of identifying melanoma risk. The dataset included information such as age, sex, medical diagnoses, medication use, and socioeconomic status. In total, 6,036,186 individuals were included, and 38,582 (0.64%) developed melanoma over the 5-year study period.
Industry News
News and Trends • Published June 12, 2026 US Pharm. 2026;51(6):58. FDA Approves Vepdegestrant for Breast Cancer The FDA approved vepdegestrant (Veppanu, Arvinas Operations, Inc.), a heterobifunctional protein degrader, for adults with estrogen receptor (ER)–positive, human epidermal growth factor receptor 2 (HER2)–negative, ESR1-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.